Page 3 - Best Kidney cancer doctors: TOP 92 doctors

Specializes in urogenital cancers with a strong research background in oncology – Dr. Sec is a member of the Turkish Medical Oncology Association.

• Over 14 years of experience of experience in medical oncology
• Published multiple studies on prognostic factors in cancer
• Works at Bahçelievler Medikalpark Hospital
• Represents specialist physicians in the Turkish Medical Oncology Association

Specializes in medical oncology with a strong focus on kidney cancer – Dr. Alemdar has extensive training from Akdeniz University.

• Completed specialized training in internal medicine and medical oncology
• Over 20 years of experience of clinical experience
• Works at Medical Park Antalya Hospital Complex

Prof. Haim Matskin heads the Urology Department at Sourasky Medical Center, specializing in kidney cancer treatments.

• Expert in brachytherapy and cryotherapy for kidney cancer
• Recognized authority in onco-urology and urology
• Member of Medical Association of Israel and international urology associations

Prof. Serkan Deveci leads urology at Medical Park Göztepe and is Section Editor for UpToDate, a major medical resource. He brings high-level expertise from both Turkey and the USA.

• Professor of urology with specialization training in the United States
• Active researcher with 620+ citations to his scientific publications
• Holds memberships in the American Urology Association and North American SMSNA
• Expert in treating complex urological conditions beyond just cancer

Prof. Köstler, an internationally recognized oncologist, brings over 22 years of experience of specialized experience to the Wiener Privatklinik.

• His expertise lies in breast cancer, gynecologic malignancies, and targeted cancer therapies.
• He is an Associate Professor at the Medical University of Vienna, focusing on translational cancer research.
• Prof. Köstler contributed to early clinical trials on personalized, targeted drug therapies.
• He leads in biomarker development and individualized systemic cancer treatment strategies.

Dr. Avi Beri specializes in kidney stones treatment and prostatectomy at Sourasky Medical Center, offering comprehensive urological care.

• Expert in transurethral resection of the prostate (TURP)
• Provides vasectomy and circumcision procedures
• Offers personalized urology consultations

Prof. Jack Baniel specializes in nerve-sparing cancer surgeries and robotic prostatectomies, with over 100 published scientific articles in uro-oncology.

• Chief of Urology at Rabin Medical Center
• Founder of oncourological Department at Beilinson Hospital
• Member of European and American Associations of Urology
• Participates in global-scale clinical uro-oncology research

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Experienced in oncology with roles at major Turkish hospitals
• Specializes in treating multiple complex cancer types
• Recognized as Associate Professor for expertise in oncology

Prof. Keil specializes in diagnostic and interventional radiology for kidney cancer, bringing precision imaging and advanced techniques to complex cases.

• Chief Physician at Academic Hospital Solingen
• Expert in MRI, CT, and interventional radiology
• Trained under Prof. Christian K. Kuhl, a radiology pioneer
• Graduated with honors from Julius-Maximilians-Universität Würzburg

Specializes in kidney cancer with expertise in immunotherapy and targeted therapy – leading treatments at Medical Center in Solingen.

• 14 years of experience in oncology with a focus on kidney cancer
• Chief Physician at a certified interdisciplinary cancer center
• Active in molecular biology research for innovative treatments
• Member of German and American oncology societies

Associate Professor Dr. Yusuf Acikgoz brings international oncology expertise from Ohio State University to Lokman Hekim University Ankara Hospital.

• Specializes in kidney cancer within medical oncology
• Assistant investigator in two major Phase III clinical trials for advanced treatments
• Completed specialized immunology-oncology training in Vienna
• Member of American Society of Clinical Oncology (ASCO)
• Certified in cutting-edge research practices from Ohio State University

Assoc. Prof. Nail Paksoy specializes in kidney cancer at Medipol Bahçelievler Hospital, with a focus on advanced treatments and clinical trials.

• ESMO Board Certified in Medical Oncology
• Published research on metastatic renal cell carcinoma
• Participated in international clinical trials for novel cancer therapies
• Associate Professor at Istanbul Medipol University

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

49 years of experience specializing in virotherapy – Dr. Jaunalksne leads the Clinical Immunology Center at Pauls Stradins University Hospital.

• Internationally trained in immunology and internal medicine
• Graduate of Riga Medical Institute
• Head of clinical immunology center – one of Latvia's leading units

Specializes in medical oncology with a focus on kidney cancer at VM Medical Park Pendik Hospital.

• Graduated from Istanbul University's Cerrahpaşa Faculty of Medicine
• Completed internal medicine residency and medical oncology subspecialty
• Over 27 years of experience of experience in internal medicine and oncology
• Worked at multiple hospitals including Şırnak State Hospital and Bağcılar Private Safa Hospital

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.